Develop Funds, an funding Advisor, launched its Q1 2026 investor letter for “GROW Small Cap Fairness Lengthy/Quick Fund”. A duplicate of the letter will be downloaded right here. In Q1 2026, GROW Small Cap Fairness Lengthy/Quick L.P (Fund) returned 4.18%, outperforming the Russell 2000 Progress Index’s –2.80%, HFRI Fairness Hedge Index’s -0.24%, and the HFRI Basic Progress Index’s 0.47% returns. Lengthy positions and hedges, and brief positions, safeguarded the portfolio amid the volatility pushed by the Iran Struggle. As well as, please examine the Technique’s high 5 holdings to know its finest picks in 2026.
In its first-quarter 2026 investor letter, Develop Funds highlighted shares like Harrow, Inc. (NASDAQ:HROW). Harrow, Inc. (NASDAQ:HROW) is a US-based pharmaceutical firm that focuses on the invention and growth of ophthalmic pharmaceutical merchandise. On June 22, 2026, Harrow, Inc. (NASDAQ:HROW) closed at $42.41 per share. One-month return of Harrow, Inc. (NASDAQ:HROW) was 24.11%, and its shares gained 33.74% over the previous 52 weeks. Harrow, Inc. (NASDAQ:HROW) has a market capitalization of $1.58 billion.
Develop Funds acknowledged the next relating to Harrow, Inc. (NASDAQ:HROW) in its Q1 2026 investor letter:
“Harrow, Inc. (NASDAQ:HROW) develops ophthalmic therapies, serving to sufferers handle power and acute eye situations. Whereas we like the corporate and its development prospects, we thought that there was a disconnect in excessive road earnings expectations versus the underlying development of the corporate. HROW disenchanted on earnings and we coated the place.”
Harrow, Inc. (NASDAQ:HROW) shouldn’t be on our checklist of 40 Most Well-liked Shares Amongst Hedge Funds Heading Into 2026. Based on our database, 22 hedge fund portfolios held Harrow, Inc. (NASDAQ:HROW) on the finish of the primary quarter, in comparison with 24 within the earlier quarter. Whereas we acknowledge the potential of Harrow, Inc. (NASDAQ:HROW) as an funding, we consider sure AI shares provide higher upside potential and carry much less draw back threat. For those who’re searching for an especially undervalued AI inventory that additionally stands to profit considerably from Trump-era tariffs and the onshoring development, see our free report on the finest short-term AI inventory.
In one other article, we coated Harrow, Inc. (NASDAQ:HROW) and shared a bullish thesis on the corporate. As well as, please try our hedge fund investor letters Q1 2026 web page for extra investor letters from hedge funds and different main buyers.
READ NEXT: 33 Shares That Ought to Double in 3 Years and 15 Shares That Will Make You Wealthy in 10 Years.
Disclosure: None. This text is initially printed at Insider Monkey.